La chemioterapia nel trattamento del carcinoma mammario.

Translated title of the contribution: Chemotherapy in the treatment of breast carcinoma

F. Conti, P. Vici

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Breast cancer (BC) is the most common malignancy and the second most common cause of cancer-related death in Western European and North American women. Neoadjuvant chemotherapy may be used in the management of both BC patients with locally advanced disease, and those with earlier stage and operable tumors. Data from recently phase III trials and worldwide consensus conference document the benefit of adjuvant chemotherapy in improving disease free survival and overall survival for patients diagnosed with invasive BC > 1 cm. When BC cells metastasize to distant organs, the disease is incurable, but chemotherapy may offer these patients a significant palliation.

Original languageItalian
Pages (from-to)181-182
Number of pages2
JournalTumori
Volume89
Issue number4 Suppl
Publication statusPublished - Jul 2003

Fingerprint

Breast Neoplasms
Drug Therapy
Second Primary Neoplasms
Therapeutics
Adjuvant Chemotherapy
Disease-Free Survival
Neoplasms
Survival

ASJC Scopus subject areas

  • Cancer Research

Cite this

La chemioterapia nel trattamento del carcinoma mammario. / Conti, F.; Vici, P.

In: Tumori, Vol. 89, No. 4 Suppl, 07.2003, p. 181-182.

Research output: Contribution to journalArticle

Conti, F & Vici, P 2003, 'La chemioterapia nel trattamento del carcinoma mammario.', Tumori, vol. 89, no. 4 Suppl, pp. 181-182.
Conti, F. ; Vici, P. / La chemioterapia nel trattamento del carcinoma mammario. In: Tumori. 2003 ; Vol. 89, No. 4 Suppl. pp. 181-182.
@article{a011bfe6e91b48648b590017eeb20043,
title = "La chemioterapia nel trattamento del carcinoma mammario.",
abstract = "Breast cancer (BC) is the most common malignancy and the second most common cause of cancer-related death in Western European and North American women. Neoadjuvant chemotherapy may be used in the management of both BC patients with locally advanced disease, and those with earlier stage and operable tumors. Data from recently phase III trials and worldwide consensus conference document the benefit of adjuvant chemotherapy in improving disease free survival and overall survival for patients diagnosed with invasive BC > 1 cm. When BC cells metastasize to distant organs, the disease is incurable, but chemotherapy may offer these patients a significant palliation.",
author = "F. Conti and P. Vici",
year = "2003",
month = "7",
language = "Italian",
volume = "89",
pages = "181--182",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "4 Suppl",

}

TY - JOUR

T1 - La chemioterapia nel trattamento del carcinoma mammario.

AU - Conti, F.

AU - Vici, P.

PY - 2003/7

Y1 - 2003/7

N2 - Breast cancer (BC) is the most common malignancy and the second most common cause of cancer-related death in Western European and North American women. Neoadjuvant chemotherapy may be used in the management of both BC patients with locally advanced disease, and those with earlier stage and operable tumors. Data from recently phase III trials and worldwide consensus conference document the benefit of adjuvant chemotherapy in improving disease free survival and overall survival for patients diagnosed with invasive BC > 1 cm. When BC cells metastasize to distant organs, the disease is incurable, but chemotherapy may offer these patients a significant palliation.

AB - Breast cancer (BC) is the most common malignancy and the second most common cause of cancer-related death in Western European and North American women. Neoadjuvant chemotherapy may be used in the management of both BC patients with locally advanced disease, and those with earlier stage and operable tumors. Data from recently phase III trials and worldwide consensus conference document the benefit of adjuvant chemotherapy in improving disease free survival and overall survival for patients diagnosed with invasive BC > 1 cm. When BC cells metastasize to distant organs, the disease is incurable, but chemotherapy may offer these patients a significant palliation.

UR - http://www.scopus.com/inward/record.url?scp=0042882134&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042882134&partnerID=8YFLogxK

M3 - Articolo

VL - 89

SP - 181

EP - 182

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 4 Suppl

ER -